Literature DB >> 26020027

Insufficient ablative margin determined by early computed tomography may predict the recurrence of hepatocellular carcinoma after radiofrequency ablation.

Wei Teng1, Ka-Wai Liu2, Chen-Chun Lin1, Wen-Juei Jeng1, Wei-Ting Chen1, I-Shyan Sheen1, Chun-Yen Lin1, Shi-Ming Lin1.   

Abstract

Tumor recurrence in hepatocellular carcinoma (HCC) patients after radiofrequency ablation (RFA) remains common; some studies have reported that insufficient ablative margin after RFA might contribute to HCC recurrence. The aim of this study was to investigate whether insufficient ablative safety margins determined by early computed tomography (CT) predicts HCC recurrence after RFA. This retrospective study recruited patients with a single HCC lesion after RFA in our department between May 2013 and March 2014. Early follow-up CT was performed within 7 days after RFA. An adequate ablative margin assessed by follow-up CT was defined as (maximum post-RFA CT radius)(3)/(maximum pre-RFA CT radius + 5 mm)(3)> 1. All patients in whom complete ablation was achieved underwent a CT scan every 3 months for early detection of HCC recurrence. In total, 72 patients (48 male, mean age 69.4 years) were analyzed. Of these, eight patients had local tumor progression, four had intra-hepatic distant recurrence, and two had extra-hepatic metastasis. Insufficient ablative margin, defined as an ablative volume with a safety margin of less than 5 mm, was an important predictor of local tumor progression (LTP) (p = 0.015) and overall recurrence (p = 0.012). The sensitivity, specificity, and positive and negative predictive values of an insufficient ablative margin for predicting LTP and overall recurrence were 36.4%, 97.2%, 50.0%, and 87.9%, and 46.2%, 89.7%, 42.9%, and 87.9%, respectively. An ablative volume with an ablative margin of less than 5 mm is associated with higher rates of both LTP and overall recurrence in HCC after RFA.

Entities:  

Keywords:  Early computed tomography; Hepatocellular carcinoma; Radiofrequency ablation; Recurrence; Safety margin

Year:  2015        PMID: 26020027      PMCID: PMC4439771          DOI: 10.1159/000343877

Source DB:  PubMed          Journal:  Liver Cancer        ISSN: 1664-5553            Impact factor:   11.740


  26 in total

1.  Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.

Authors:  Ryosuke Tateishi; Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Yukihiro Koike; Tomonori Fujishima; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Cancer       Date:  2005-03-15       Impact factor: 6.860

2.  Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images.

Authors:  Kyung Won Kim; Jeong Min Lee; Ernst Klotz; Soo Jin Kim; Se Hyung Kim; Ji Young Kim; Joon Koo Han; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2011-05       Impact factor: 3.959

3.  Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.

Authors:  Sooyoung Shin; Jeong Min Lee; Kyung Won Kim; Ijin Joo; Joon Koo Han; Byung Ihn Choi; Ernst Klotz
Journal:  AJR Am J Roentgenol       Date:  2014-07       Impact factor: 3.959

4.  Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin.

Authors:  Takahide Nakazawa; Shigehiro Kokubu; Akitaka Shibuya; Koji Ono; Masaaki Watanabe; Hisashi Hidaka; Takeshi Tsuchihashi; Katsunori Saigenji
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

5.  Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract.

Authors:  Y Kondo; H Yoshida; S Shiina; R Tateishi; T Teratani; M Omata
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

Review 6.  Local ablation for hepatocellular carcinoma in taiwan.

Authors:  Shi-Ming Lin
Journal:  Liver Cancer       Date:  2013-04       Impact factor: 11.740

7.  Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors.

Authors:  Kun Yan; Min Hua Chen; Wei Yang; Yan Bin Wang; Wen Gao; Chun Yi Hao; Bao Cai Xing; Xin Fu Huang
Journal:  Eur J Radiol       Date:  2007-08-31       Impact factor: 3.528

8.  Diagnostic performance of contrast-enhanced computed tomography in the immediate assessment of radiofrequency ablation success in colorectal liver metastases.

Authors:  Christina Schraml; Stephan Clasen; Nina F Schwenzer; Ingmar Koenigsrainer; Tina Herberts; Claus D Claussen; Philippe L Pereira
Journal:  Abdom Imaging       Date:  2008 Nov-Dec

9.  Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites.

Authors:  Takahide Uehara; Masashi Hirooka; Kiyotaka Ishida; Atsushi Hiraoka; Teru Kumagi; Yoshiyasu Kisaka; Yoichi Hiasa; Morikazu Onji
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

10.  Incomplete thermal ablation of hepatocellular carcinoma: effects on tumor proliferation.

Authors:  Yan Li; Russell E Brown; Robert C G Martin
Journal:  J Surg Res       Date:  2012-07-24       Impact factor: 2.192

View more
  25 in total

1.  Locoregional Therapy for Hepatocellular Carcinoma.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-06-05       Impact factor: 11.740

2.  Percutaneous cryoablation in early stage hepatocellular carcinoma: analysis of local tumor progression factors.

Authors:  Dong Kyu Kim; Kichang Han; Jong Yun Won; Gyoung Min Kim; Joon Ho Kwon; Man Deuk Kim
Journal:  Diagn Interv Radiol       Date:  2020-03       Impact factor: 2.630

3.  Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.

Authors:  Xiao-Wan Bo; Hui-Xiong Xu; Le-Hang Guo; Li-Ping Sun; Xiao-Long Li; Chong-Ke Zhao; Ya-Ping He; Bo-Ji Liu; Dan-Dan Li; Kun Zhang; Dan Wang
Journal:  Br J Radiol       Date:  2017-07-27       Impact factor: 3.039

4.  Breakthrough Imaging in Hepatocellular Carcinoma.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-12-18       Impact factor: 11.740

5.  Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-12-15       Impact factor: 11.740

6.  Heterogeneity and Subclassification of Barcelona Clinic Liver Cancer Stage B.

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2016-03-17       Impact factor: 11.740

7.  Short-Term Results of Laparoscopic Radiofrequency Ablation Using a Multipolar System for Localized Hepatocellular Carcinoma.

Authors:  Naoki Morimoto; Norio Isoda; Yoshinari Takaoka; Takuya Hirosawa; Shunji Watanabe; Toshiya Otake; Kozue Murayama; Takeshi Fujieda; Mamiko Tsukui; Natsumi Miyata; Kohei Ono; Shota Yamaguchi; Hironori Yamamoto
Journal:  Liver Cancer       Date:  2016-12-17       Impact factor: 11.740

Review 8.  Thermal Ablation of Metastatic Colon Cancer to the Liver.

Authors:  Juan C Camacho; Elena N Petre; Constantinos T Sofocleous
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

Review 9.  Individualized Ablation of Hepatocellular Carcinoma: Tailored Approaches across the Phenotype Spectrum.

Authors:  Zlatko Devcic; Mohamed Elboraey; Lucas Vidal; Kabir Mody; Denise Harnois; Tushar Patel; Beau B Toskich
Journal:  Semin Intervent Radiol       Date:  2019-10-31       Impact factor: 1.513

10.  Moderate hyperthermic heating encountered during thermal ablation increases tumor cell activity.

Authors:  Aurelia Markezana; Muneeb Ahmed; Gaurav Kumar; Elina Zorde-Khvalevsky; Nir Rozenblum; Eithan Galun; S Nahum Goldberg
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.